292 related articles for article (PubMed ID: 36047634)
1.
Yılmaz Çolak Ç; Tefon Öztürk BE
Pathog Glob Health; 2023 Jun; 117(4):342-355. PubMed ID: 36047634
[No Abstract] [Full Text] [Related]
2. A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against
Zurita ME; Wilk MM; Carriquiriborde F; Bartel E; Moreno G; Misiak A; Mills KHG; Hozbor D
Front Cell Infect Microbiol; 2019; 9():125. PubMed ID: 31106160
[TBL] [Abstract][Full Text] [Related]
3. Outer membrane vesicles derived from Bordetella parapertussis as an acellular vaccine against Bordetella parapertussis and Bordetella pertussis infection.
Bottero D; Gaillard ME; Errea A; Moreno G; Zurita E; Pianciola L; Rumbo M; Hozbor D
Vaccine; 2013 Oct; 31(45):5262-8. PubMed ID: 24012570
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the immune response induced by pertussis OMVs-based vaccine.
Bottero D; Gaillard ME; Zurita E; Moreno G; Martinez DS; Bartel E; Bravo S; Carriquiriborde F; Errea A; Castuma C; Rumbo M; Hozbor D
Vaccine; 2016 Jun; 34(28):3303-9. PubMed ID: 27151884
[TBL] [Abstract][Full Text] [Related]
5. Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes.
Gaillard ME; Bottero D; Errea A; Ormazábal M; Zurita ME; Moreno G; Rumbo M; Castuma C; Bartel E; Flores D; van der Ley P; van der Ark A; F Hozbor D
Vaccine; 2014 Feb; 32(8):931-7. PubMed ID: 24397896
[TBL] [Abstract][Full Text] [Related]
6. Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate.
Asensio CJ; Gaillard ME; Moreno G; Bottero D; Zurita E; Rumbo M; van der Ley P; van der Ark A; Hozbor D
Vaccine; 2011 Feb; 29(8):1649-56. PubMed ID: 21211579
[TBL] [Abstract][Full Text] [Related]
7. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.
Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK
Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393
[TBL] [Abstract][Full Text] [Related]
8. Pertussis: Where did we go wrong and what can we do about it?
Locht C
J Infect; 2016 Jul; 72 Suppl():S34-40. PubMed ID: 27161992
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Two Different Methods for the Extraction of Outer Membrane Vesicles from the
Soltani MS; Eftekhar F; Noofeli M; Banihashemi SR; Shahcheraghi F
Arch Razi Inst; 2021; 76(3):411-419. PubMed ID: 34824734
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the key antigenic components of pertussis vaccine based on outer membrane vesicles.
Ormazábal M; Bartel E; Gaillard ME; Bottero D; Errea A; Zurita ME; Moreno G; Rumbo M; Castuma C; Flores D; Martín MJ; Hozbor D
Vaccine; 2014 Oct; 32(46):6084-90. PubMed ID: 25240753
[TBL] [Abstract][Full Text] [Related]
11. Canonical and Non-canonical Inflammasome Activation by Outer Membrane Vesicles Derived From
Elizagaray ML; Gomes MTR; Guimaraes ES; Rumbo M; Hozbor DF; Oliveira SC; Moreno G
Front Immunol; 2020; 11():1879. PubMed ID: 32973778
[TBL] [Abstract][Full Text] [Related]
12. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.
Hegerle N; Guiso N
Expert Rev Vaccines; 2014 Sep; 13(9):1135-46. PubMed ID: 24953157
[TBL] [Abstract][Full Text] [Related]
13. Outer Membrane Vesicles (OMV)-based and Proteomics-driven Antigen Selection Identifies Novel Factors Contributing to
Gasperini G; Biagini M; Arato V; Gianfaldoni C; Vadi A; Norais N; Bensi G; Delany I; Pizza M; Aricò B; Leuzzi R
Mol Cell Proteomics; 2018 Feb; 17(2):205-215. PubMed ID: 29203497
[TBL] [Abstract][Full Text] [Related]
14. Pertussis vaccination and whooping cough: and now what?
Guiso N
Expert Rev Vaccines; 2014 Oct; 13(10):1163-5. PubMed ID: 25020131
[TBL] [Abstract][Full Text] [Related]
15. Antibody Specificity Following a Recent
Raeven RHM; van der Maas L; Pennings JLA; Fuursted K; Jørgensen CS; van Riet E; Metz B; Kersten GFA; Dalby T
Front Immunol; 2019; 10():1364. PubMed ID: 31275314
[No Abstract] [Full Text] [Related]
16. Evaluation of Outer Membrane Vesicles Obtained from Predominant Local Isolate of Boredetella pertussis as a Vaccine Candidate.
Soltani MS; Noofeli M; Banihashemi SR; Shahcheraghi F; Eftekhar F
Iran Biomed J; 2021 Nov; 25(6):399-407. PubMed ID: 34719226
[TBL] [Abstract][Full Text] [Related]
17. Pertussis vaccines: state-of-the-art and future trends.
Tefon BE; Özcengiz E; Özcengiz G
Curr Top Med Chem; 2013; 13(20):2581-96. PubMed ID: 24066885
[TBL] [Abstract][Full Text] [Related]
18. Cross-species protection mediated by a Bordetella bronchiseptica strain lacking antigenic homologs present in acellular pertussis vaccines.
Sukumar N; Sloan GP; Conover MS; Love CF; Mattoo S; Kock ND; Deora R
Infect Immun; 2010 May; 78(5):2008-16. PubMed ID: 20176797
[TBL] [Abstract][Full Text] [Related]
19. Roads to the development of improved pertussis vaccines paved by immunology.
Brummelman J; Wilk MM; Han WG; van Els CA; Mills KH
Pathog Dis; 2015 Nov; 73(8):ftv067. PubMed ID: 26347400
[TBL] [Abstract][Full Text] [Related]
20. Acellular pertussis vaccines and pertussis resurgence: revise or replace?
Ausiello CM; Cassone A
mBio; 2014 Jun; 5(3):e01339-14. PubMed ID: 24917600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
